JDR
BIIB icon

Jay D. Rosenbaum’s Biogen BIIB Stock Holding History

Jay D. Rosenbaum’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,771
Closed -$419K – 51
2019
Q1 		$419K Sell
1,771
-30
-2% -$9.45K 0.79% 46
2018
Q4 		$542K Sell
1,801
-44
-2% -$14K 1.15% 35
2018
Q3 		$652K Sell
1,845
-230
-11% -$79.2K 1.18% 34
2018
Q2 		$602K Sell
2,075
-54
-3% -$15.2K 1.19% 33
2018
Q1 		$583K Buy
2,129
+25
+1% +$7.76K 1.18% 34
2017
Q4 		$670K Hold
2,104
– – 1.23% 33
2017
Q3 		$659K Buy
2,104
+175
+9% +$51.8K 1.26% 32
2017
Q2 		$523K Buy
1,929
+225
+13% +$59.5K 1.04% 38
2017
Q1 		$466K Buy
1,704
+275
+19% +$77.8K 0.99% 37
2016
Q4 		$405K Buy
1,429
+120
+9% +$35.6K 0.94% 37
2016
Q3 		$410K Buy
1,309
+270
+26% +$80K 0.05% 37
2016
Q2 		$251K Buy
+1,039
New +$274K 0.04% 46

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jay D. Rosenbaum's BIIB Position: Q2 2019 in Review

Jay D. Rosenbaum sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,771 shares — an estimated $419K sold.

Jay D. Rosenbaum first reported a position in BIIB in Q2 2016 and held it in 12 quarters. The position peaked at $670K in Q4 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Jay D. Rosenbaum reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Jay D. Rosenbaum sold 1,771 Biogen shares in Q2 2019, an estimated $419K.
  • Jay D. Rosenbaum first reported a position in Biogen in Q2 2016 and held it in 12 quarters.
  • Jay D. Rosenbaum's Biogen position peaked at $670K in Q4 2017.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Jay D. Rosenbaum's 13F filing for Q2 2019, filed 1 Aug 2019.